Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keromask masking cream
130802000BBBCAB
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 790 |
|
Gamolenic acid 80mg capsules
1305010I0AAABAB
|
Gamolenic acid (Eczema) | Gamolenic acid | Skin | 785 |
|
Fluocinolone acetonide 0.00625% ointment
1304000N0AABCBC
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 774 |
|
Lamisil 1% cream
131002030BBAAAA
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 763 |
|
Aknemycin Plus solution
1306010I0BFAAAF
|
Aknemycin Plus | Erythromycin | Skin | 762 |
|
Covermark classic foundation
130802000BBANA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 759 |
|
Soya oil 84.75% bath oil
130201100AAAAAA
|
Generic compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 757 |
|
Hydrocortisone butyrate 0.1% ointment
1304000W0AABABA
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | 746 |
|
Betamethasone valerate 0.1% / Neomycin 0.5% ointment
1304000F0AACECE
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 729 |
|
Psoriderm cream
1305020C0BDABBC
|
Psoriderm (Topical) | Tars | Skin | 729 |
|
Betnovate 0.1% lotion
1304000F0BBAIBC
|
Betnovate (Topical) | Betamethasone valerate | Skin | 713 |
|
Locoid 0.1% ointment
1304000W0BBACBA
|
Locoid | Hydrocortisone butyrate | Skin | 709 |
|
Coal tar 2.5% scalp lotion
1309000C0AAAEAE
|
Coal tar (Scalp) | Coal tar | Skin | 698 |
|
Zindaclin 1% gel
1306010F0BCAAAD
|
Zindaclin | Clindamycin phosphate | Skin | 698 |
|
Podophyllotoxin 0.5% solution
1307000K0AAAAAA
|
Podophyllotoxin | Podophyllotoxin | Skin | 689 |
|
Hydrocortisone butyrate 0.1% scalp lotion
1304000W0AABBBB
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | 682 |
|
Clobavate 0.05% ointment
1304000H0BDAABA
|
Clobavate | Clobetasone butyrate | Skin | 681 |
|
Nystaform cream
1310020U0BCAAAE
|
Nystaform | Nystatin | Skin | 664 |
|
Terbinafine 1% gel
131002030AAACAC
|
Terbinafine hydrochloride (Topical) | Terbinafine hydrochloride | Skin | 664 |
|
Curatoderm 4micrograms/g ointment
1305020R0BBAAAA
|
Curatoderm | Tacalcitol | Skin | 650 |
|
Xemacort 20mg/g / 1mg/g cream
1304000F0BHAACC
|
Xemacort | Betamethasone valerate | Skin | 644 |
|
Synalar 1 in 4 Dilution 0.00625% cream
1304000N0BBADAD
|
Synalar | Fluocinolone acetonide | Skin | 641 |
|
Chlorhexidine gluconate 0.5% solution
1311020L0AAALAL
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 635 |
|
Nystatin 100,000units/g / Chlorhexidine hydrochloride 1% crm
1310020U0AAAEAE
|
Nystatin (Topical) | Nystatin | Skin | 623 |
|
Aklief 50micrograms/g cream
1306010ACBBAAAA
|
Aklief | Trifarotene | Skin | 614 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.